TARGETING LSD1 RESCUES MHC-I ANTIGEN PRESENTATION AND OVERCOMES RESISTANCE TO PDL1 BLOCKADE THERAPY IN SMALL CELL LUNG CANCER

被引：0
|
作者：
Nguyen, Evelyn [1 ]
Chow, Andrew [1 ]
Rudin, Charles [1 ]
Sen, Triparna [1 ]
Taniguchi, Hirokazu [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0915
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
915
引用
收藏
页码：A954 / A954
页数：1
相关论文
共 50 条
  • [1] Targeting LSD1 rescues MHC-I antigen presentation in small cell lung cancer
    Nguyen, Minh N.
    Taniguchi, Hirokazu
    Chow, Andrew
    Zhan, Yingqian A.
    Sen, Triparna
    Rudin, Charles M.
    CANCER RESEARCH, 2022, 82 (12)
  • [2] Targeting LSD1 rescues MHC class I antigen presentation and promotes immune checkpoint blockade response in small cell lung cancer
    Nguyen, Evelyn M.
    Taniguchi, Hirokazu
    Chow, Andrew
    Sen, Triparna
    Rudin, Charles M.
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [3] Targeting LSD1 in small cell lung cancer
    Sarah Crunkhorn
    Nature Reviews Drug Discovery, 2015, 14 (9) : 602 - 602
  • [4] Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition
    Augert, Arnaud
    Eastwood, Emily
    Ibrahim, Ali H.
    Wu, Nan
    Grunblatt, Eli
    Basom, Ryan
    Eaton, Keith D.
    Martins, Renato
    Poirier, John
    Rudin, Charles M.
    Milletti, Francesca
    Mack, Fiona
    MacPherson, David
    CLINICAL CANCER RESEARCH, 2018, 24 (17)
  • [5] Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition
    Augert, Arnaud
    Eastwood, Emily
    Ibrahim, Ali H.
    Wu, Nan
    Grunblatt, Eli
    Basom, Ryan
    Liggitt, Denny
    Eaton, Keith D.
    Martins, Renato
    Poirier, John T.
    Rudin, Charles M.
    Milletti, Francesca
    Cheng, Wei-Yi
    Mack, Fiona
    MacPherson, David
    SCIENCE SIGNALING, 2019, 12 (567)
  • [6] LSD1 inhibition restores MHC class I expression and augments the anti-tumor response of immune checkpoint blockade in small cell lung cancer
    Sen, T.
    Nguyen, M. N.
    Taniguchi, H.
    Chow, A.
    De Stanchina, E.
    Rudin, C. M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1432 - S1432
  • [7] Altering the Course of Small Cell Lung Cancer: Targeting Cancer Stem Cells via LSD1 Inhibition
    Stewart, C. Allison
    Byers, Lauren Averett
    CANCER CELL, 2015, 28 (01) : 4 - 6
  • [8] Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death- Ligand 1 Blockade Resistance in SCLC
    Nguyen, Evelyn M.
    Taniguchi, Hirokazu
    Chan, Joseph M.
    Zhan, Yingqian A.
    Chen, Xiaoping
    Qiu, Juan
    de Stanchina, Elisa
    Allaj, Viola
    Shah, Nisargbhai S.
    Uddin, Fathema
    Manoj, Parvathy
    Liu, Michael
    Cai, Sheng F.
    Levine, Ross
    Quintanal-Villalonga, Alvaro
    Sen, Triparna
    Chow, Andrew
    Rudin, Charles M.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (08) : 1014 - 1031
  • [9] Inhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing
    Hiatt, Joseph B.
    Sandborg, Holly
    Garrison, Sarah M.
    Arnold, Henry U.
    Liao, Sheng-You
    Norton, Justin P.
    Friesen, Travis J.
    Wu, Feinan
    Sutherland, Kate D.
    Rienhoff Jr, Hugh Y.
    Martins, Renato
    Houghton, A. McGarry
    Srivastava, Shivani
    MacPherson, David
    CLINICAL CANCER RESEARCH, 2022, 28 (20) : 4551 - 4564
  • [10] New PDL1 inhibitors for non-small cell lung cancer: focus on pembrolizumab
    Bylicki, Olivier
    Paleiron, Nicolas
    Rousseau-Bussac, Gaelle
    Chouaid, Christos
    ONCOTARGETS AND THERAPY, 2018, 11 : 4051 - 4064
12345